PREDAIR FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Predair Forte, and what generic alternatives are available?
Predair Forte is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in PREDAIR FORTE is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Predair Forte
A generic version of PREDAIR FORTE was approved as prednisolone sodium phosphate by BAUSCH AND LOMB on July 29th, 1994.
Summary for PREDAIR FORTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Patent Applications: | 4,943 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PREDAIR FORTE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PREDAIR FORTE
US Patents and Regulatory Information for PREDAIR FORTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmafair | PREDAIR FORTE | prednisolone sodium phosphate | SOLUTION/DROPS;OPHTHALMIC | 088165-001 | Mar 28, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |